Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes

An overview is presented on current antiinflammatory, cytostatic/cytotoxic and immunomodulatory treatments for immunologically mediated inflammatory myopathies with skin involvement. High-dose intravenous immunoglobulin (IVIG) therapy is discussed in the context of recent findings regarding pathogen...

Full description

Saved in:
Bibliographic Details
Published inWiener Klinische Wochenschrift Vol. 108; no. 22; p. 705
Main Authors Göttfried, I, Seeber, A, Anegg, B, Pirkhammer, D, Rieger, A, Stingl, G, Volc-Platzer, B
Format Journal Article
LanguageGerman
Published Austria 29.11.1996
Subjects
Anti-Inflammatory Agents - therapeutic use
Blood Component Removal
Combined Modality Therapy
Dermatomyositis - immunology
Dermatomyositis - therapy
Glucocorticoids - therapeutic use
Humans
Immunization, Passive
Immunosuppressive Agents - therapeutic use
Photopheresis
Polymyositis - immunology
Polymyositis - therapy
Steroids
Online AccessGet more information

Cover

More Information
Summary:An overview is presented on current antiinflammatory, cytostatic/cytotoxic and immunomodulatory treatments for immunologically mediated inflammatory myopathies with skin involvement. High-dose intravenous immunoglobulin (IVIG) therapy is discussed in the context of recent findings regarding pathogenic mechanisms of autoimmune diseases.
ISSN:0043-5325